Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
Editorials & Other Articles
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
Four States Urge FDA to Follow Science and Remove Abortion Pill Restrictions
Attorneys general of four states—Massachusetts, California, New Jersey and New York—asked the U.S. Food and Drug Administration (FDA) on Thursday, June 5, to lift long-standing restrictions on the medication mifepristone. The drug is used in approximately two-thirds of abortions in the United States.
In a 54-page citizen petition, attorneys general Andrea Joy Campbell of Massachusetts, Rob Bonta of California, Matthew J. Platkin of New Jersey and Leticia James of New York argued the FDA’s mifepristone restrictions are medically unjustified, burdensome on patient access and place undue strain on the nation’s healthcare system.
The petition came just three days after the FDA commissioner Marty Makary announced his decision to “review” the agency’s regulation of mifepristone after previously stating he had no plans to restrict the medication. The decision was in response to a letter from Sen. Josh Hawley citing a flawed antiabortion report falsely claiming mifepristone is riskier than previously believed.
The FDA approved mifepristone in combination with a second mediation—misoprostol—for ending early pregnancies in 2000. Since then, the medication has been used safely by 7.5 million women. Over 100 peer-reviewed studies have shown mifepristone is safe—in fact safer than many medications without such restrictions, such as penicillin, Viagra and Tylenol.
In a 54-page citizen petition, attorneys general Andrea Joy Campbell of Massachusetts, Rob Bonta of California, Matthew J. Platkin of New Jersey and Leticia James of New York argued the FDA’s mifepristone restrictions are medically unjustified, burdensome on patient access and place undue strain on the nation’s healthcare system.
The petition came just three days after the FDA commissioner Marty Makary announced his decision to “review” the agency’s regulation of mifepristone after previously stating he had no plans to restrict the medication. The decision was in response to a letter from Sen. Josh Hawley citing a flawed antiabortion report falsely claiming mifepristone is riskier than previously believed.
The FDA approved mifepristone in combination with a second mediation—misoprostol—for ending early pregnancies in 2000. Since then, the medication has been used safely by 7.5 million women. Over 100 peer-reviewed studies have shown mifepristone is safe—in fact safer than many medications without such restrictions, such as penicillin, Viagra and Tylenol.
https://msmagazine.com/2025/06/06/fda-mifepristone-attorney-general-california-new-york-new-jersey-massachusetts/